Akiko Uchida, Yasushi Isobe, Junko Asano, Yu Uemura, Masahiro Hoshikawa, Masayuki Takagi and Ikuo Miura (2019) “Targeting BCL2 with venetoclax is a promising therapeutic strategy for ‘double-proteinexpression’ lymphoma with MYC and BCL2 rearrangements”, Haematologica. Pavia, Italy, 104(7), pp. 1417-1421. doi: 10.3324/haematol.2018.204958.